Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugging the Cancers Addicted to DNA Repair
Jac A. Nickoloff, Dennie V. Jones, Suk‐Hee Lee, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 11
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

The rediscovery of platinum-based cancer therapy
Sven Rottenberg, Carmen A. Widmer, Paola Perego
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 37-50
Closed Access | Times Cited: 688
ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease
Bernhard Lüscher, Mareike Bütepage, Laura Eckei, et al.
Chemical Reviews (2017) Vol. 118, Iss. 3, pp. 1092-1136
Closed Access | Times Cited: 224
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Isabella Faraoni, Grazia Graziani
Cancers (2018) Vol. 10, Iss. 12, pp. 487-487
Open Access | Times Cited: 196
DNA Damage: From Threat to Treatment
Antonio Carusillo, Claudio Mussolino
Cells (2020) Vol. 9, Iss. 7, pp. 1665-1665
Open Access | Times Cited: 181
Clustered DNA Double-Strand Breaks: Biological Effects and Relevance to Cancer Radiotherapy
Jac A. Nickoloff, Neelam Sharma, Lynn Taylor
Genes (2020) Vol. 11, Iss. 1, pp. 99-99
Open Access | Times Cited: 156
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 141
Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response
Mahmoud Toulany
Genes (2019) Vol. 10, Iss. 1, pp. 25-25
Open Access | Times Cited: 131
Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells
Simone Lieb, Silvia Blaha-Ostermann, Elisabeth Kamper, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 108
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
Elisa Taìana, Vanessa Favasuli, Domenica Ronchetti, et al.
Leukemia (2019) Vol. 34, Iss. 1, pp. 234-244
Closed Access | Times Cited: 96
Role of Rad51 and DNA repair in cancer: A molecular perspective
Erik Laurini, Domenico Marson, Alice Fermeglia, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107492-107492
Open Access | Times Cited: 88
DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma
Xiangqi Meng, Chunbin Duan, Hengyuan Pang, et al.
EBioMedicine (2019) Vol. 41, pp. 185-199
Open Access | Times Cited: 78
DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage
Thom G. A. Reuvers, Roland Kanaar, Julie Nonnekens
Cancers (2020) Vol. 12, Iss. 8, pp. 2098-2098
Open Access | Times Cited: 73
Nanomedicines with high drug availability and drug sensitivity overcome hypoxia-associated drug resistance
Yi Liu, Wang Dong, Yinchu Ma, et al.
Biomaterials (2023) Vol. 294, pp. 122023-122023
Closed Access | Times Cited: 23
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape
Ashaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.
Life (2024) Vol. 14, Iss. 2, pp. 198-198
Open Access | Times Cited: 10
The Interplay Between Chromatin Remodeling and DNA Double-strand Break Repair: Implications for Cancer Biology and Therapeutics
Liu‐Jun He, Jaeyoung Moon, Chenghui Cai, et al.
DNA repair (2025) Vol. 146, pp. 103811-103811
Open Access | Times Cited: 1
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
Meenakshi Anurag, Nindo Punturi, Jeremy Hoog, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 19, pp. 4887-4899
Open Access | Times Cited: 76
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
Katherine Sullivan-Reed, Elisabeth Bolton-Gillespie, Yashodhara Dasgupta, et al.
Cell Reports (2018) Vol. 23, Iss. 11, pp. 3127-3136
Open Access | Times Cited: 75
Targeting DNA Damage Response in Prostate and Breast Cancer
Antje M. Wengner, Arne Scholz, Bernard Haendler
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8273-8273
Open Access | Times Cited: 70
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma
Pavlos Msaouel, Nizar M. Tannir, Cheryl L. Walker
Clinical Cancer Research (2018) Vol. 24, Iss. 9, pp. 2044-2049
Open Access | Times Cited: 66
The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness
Bleddyn Jones, Stephen J. McMahon, Kevin M. Prise
Clinical Oncology (2018) Vol. 30, Iss. 5, pp. 285-292
Open Access | Times Cited: 64
DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns
Richa Sharma, Sara Lewis, Marcin W. Włodarski
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 62
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts
Hung‐Ming Lam, Holly M. Nguyen, Mark P. Labrecque, et al.
European Urology (2019) Vol. 77, Iss. 2, pp. 144-155
Open Access | Times Cited: 59
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
Yingying Wang, Qian Ma, Shaolu Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 56
The Effects of Localized Heat on the Hallmarks of Cancer
Gary Hannon, Felista L. Tansi, Ingrid Hilger, et al.
Advanced Therapeutics (2021) Vol. 4, Iss. 7
Closed Access | Times Cited: 49
The evolving role of DNA inter-strand crosslinks in chemotherapy
Halley B. Rycenga, David T. Long
Current Opinion in Pharmacology (2018) Vol. 41, pp. 20-26
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top